KNC / USDT

KNC / BTC

IDEX / USDT

IDEX / USDC

BAKE / USDT

BAKE / BTC

BAKE / TRY

MDT / USDT

ARK / USDT

ARK / TRY

BANANAS31 / USDT

BANANAS31 / USDC

HYPER / BNB

HYPER / USDC

HYPER / USDT

HYPER / TRY

OMNI / BTC

OMNI / FDUSD

OMNI / USDT

OMNI / TRY

VERTOZ LIMITED

SOMA TEXTILES & INDUST LT

FORGE AUTO INTERNATION L

MAXPOSURE LIMITED

VISAMAN GLOBAL SALES LTD

TARMAT LIMITED

GLENMARK PHARMACEUTICALS

SALONA COTSPIN LTD.

ENVIRO INFRA ENGINEERS L

SIGNPOST INDIA LIMITED

ROTO PUMPS LIMITED

DYNAMIC CABLES LIMITED

MIRAEAMC - INTERNET

PARSVNATH DEVELOPER LTD

DCM LTD

PENINSULA LAND LIMITED

JINDAL WORLDWIDE LTD

ZOTA HEALTH CARE LIMITED

PC JEWELLER LTD

PTL ENTERPRISES LTD

Click here to get full coverage on Lupin receives FDA approval for generic Lotemax - Drug Store News

Lupin receives FDA approval for generic Lotemax  Drug Store News

Lupin receives FDA approval for generic Lotemax - Drug Store News

Click here to get full coverage on ‘Lupin’ Returning for Season 4 - The Hollywood Reporter

‘Lupin’ Returning for Season 4  The Hollywood Reporter

‘Lupin’ Returning for Season 4 - The Hollywood Reporter

Click here to get full coverage on Lupin Part 4 Is Now in Production in Paris - Netflix

Lupin Part 4 Is Now in Production in Paris  Netflix

Lupin Part 4 Is Now in Production in Paris - Netflix

Click here to get full coverage on Lupin’s Cimzia Biosimilar Candidate Reflects Strategy To Separate Wheat From Chaff - insights.citeline.com

Lupin’s Cimzia Biosimilar Candidate Reflects Strategy To Separate Wheat From Chaff  insights.citeline.com

Lupin’s Cimzia Biosimilar Candidate Reflects Strategy To Separate Wheat From Chaff - insights.citeline.com

Click here to get full coverage on Zentiva, Lupin collaborate on commercialising Certolizumab Pegol - World Pharmaceutical Frontiers

Zentiva, Lupin collaborate on commercialising Certolizumab Pegol  World Pharmaceutical Frontiers

Zentiva, Lupin collaborate on commercialising Certolizumab Pegol - World Pharmaceutical Frontiers

Click here to get full coverage on Lupin receives FDA approval for Loteprednol Etabonate Ophthalmic Gel, 0.38% - Ophthalmology Times

Lupin receives FDA approval for Loteprednol Etabonate Ophthalmic Gel, 0.38%  Ophthalmology Times

Lupin receives FDA approval for Loteprednol Etabonate Ophthalmic Gel, 0.38% - Ophthalmology Times

Click here to get full coverage on Here’s the Definitive Top 10 Netflix Shows of All Time (For Now) - Pajiba

Here’s the Definitive Top 10 Netflix Shows of All Time (For Now)  Pajiba

Here’s the Definitive Top 10 Netflix Shows of All Time (For Now) - Pajiba

Click here to get full coverage on Freddie Highmore Poised for French-Language Acting Debut in Edgar Allan Poe Series From ‘Lupin’ Producer Gaumont and TF1 (EXCLUSIVE) - Variety

Freddie Highmore Poised for French-Language Acting Debut in Edgar Allan Poe Series From ‘Lupin’ Producer Gaumont and TF1 (EXCLUSIVE)  Variety

Freddie Highmore Poised for French-Language Acting Debut in Edgar Allan Poe Series From ‘Lupin’ Producer Gaumont and TF1 (EXCLUSIVE) - Variety

Click here to get full coverage on ‘Lupin 4’ Confirmed By Netflix As Shoot With Omar Sy Begins In Paris - Deadline

‘Lupin 4’ Confirmed By Netflix As Shoot With Omar Sy Begins In Paris  Deadline

‘Lupin 4’ Confirmed By Netflix As Shoot With Omar Sy Begins In Paris - Deadline

Click here to get full coverage on Trump tariff: Pharma stocks Aurobindo, DRL, Lupin, Sun Pharma in focus today; here's why - MSN

Trump tariff: Pharma stocks Aurobindo, DRL, Lupin, Sun Pharma in focus today; here's why  MSN

Trump tariff: Pharma stocks Aurobindo, DRL, Lupin, Sun Pharma in focus today; here's why - MSN

Click here to get full coverage on Lupin poisoning: a review - Frontiers

Lupin poisoning: a review - Frontiers

Click here to get full coverage on Lupin and Honeywell Move Forward Jointly with Plans for HFO Technology in Inhalers - PR Newswire

Lupin and Honeywell Move Forward Jointly with Plans for HFO Technology in Inhalers  PR Newswire

Lupin and Honeywell Move Forward Jointly with Plans for HFO Technology in Inhalers - PR Newswire

Click here to get full coverage on Lupin, Biocon Leading Gains Amid Trumps Threats Of 200% Tariff On Drug Import - NDTV Profit

Lupin, Biocon Leading Gains Amid Trumps Threats Of 200% Tariff On Drug Import  NDTV Profit

Lupin, Biocon Leading Gains Amid Trumps Threats Of 200% Tariff On Drug Import - NDTV Profit

Click here to get full coverage on Lupin recalls nearly 3,000 bottles of OCD medication in the US after subpar stability testing results - Fierce Pharma

Lupin recalls nearly 3,000 bottles of OCD medication in the US after subpar stability testing results  Fierce Pharma

Lupin recalls nearly 3,000 bottles of OCD medication in the US after subpar stability testing results - Fierce Pharma

Click here to get full coverage on FDA Approves Lupin’s Generic Tolvaptan Tablets - Docwire News

FDA Approves Lupin’s Generic Tolvaptan Tablets  Docwire News

FDA Approves Lupin’s Generic Tolvaptan Tablets - Docwire News

Click here to get full coverage on The unexplored diversity of rough-seeded lupins provides rich genomic resources and insights into lupin evolution - Nature

The unexplored diversity of rough-seeded lupins provides rich genomic resources and insights into lupin evolution  Nature

The unexplored diversity of rough-seeded lupins provides rich genomic resources and insights into lupin evolution - Nature

Click here to get full coverage on Lupin, Zentiva ink pact for biosimilar - The Hindu

Lupin, Zentiva ink pact for biosimilar  The Hindu

Lupin, Zentiva ink pact for biosimilar - The Hindu

Click here to get full coverage on Lupin signs $50 million licensing deal with Zentiva to commercialise Certolizumab Pegol across global mark - The Economic Times

Lupin signs $50 million licensing deal with Zentiva to commercialise Certolizumab Pegol across global mark  The Economic Times

Lupin signs $50 million licensing deal with Zentiva to commercialise Certolizumab Pegol across global mark - The Economic Times

Click here to get full coverage on In Arsene Lupin - Once a Thief you play as both master burglar and detective - Epic Games

In Arsene Lupin - Once a Thief you play as both master burglar and detective  Epic Games

In Arsene Lupin - Once a Thief you play as both master burglar and detective - Epic Games

Click here to get full coverage on Lupin Announces Presentation of Phase 1 Data on LNP7457 (PRMT5 inhibitor) at the American Society of Clinical Oncology - Annual Meeting 2025 - PR Newswire

Lupin Announces Presentation of Phase 1 Data on LNP7457 (PRMT5 inhibitor) at the American Society of Clinical Oncology - Annual Meeting 2025  PR Newswire

Lupin Announces Presentation of Phase 1 Data on LNP7457 (PRMT5 inhibitor) at the American Society of Clinical Oncology - Annual Meeting 2025 - PR Newswire

Click here to get full coverage on Boss Of ‘Lupin’ Maker Gaumont TV France On Netflix’s Response To Streaming Law: “They Did Everything To Avoid It, But They Respect It” – Conecta Fiction - Deadline

Boss Of ‘Lupin’ Maker Gaumont TV France On Netflix’s Response To Streaming Law: “They Did Everything To Avoid It, But They Respect It” – Conecta Fiction  Deadline

Boss Of ‘Lupin’ Maker Gaumont TV France On Netflix’s Response To Streaming Law: “They Did Everything To Avoid It, But They Respect It” – Conecta Fiction - Deadline

Click here to get full coverage on India's Lupin to spin off consumer healthcare business - Reuters

India's Lupin to spin off consumer healthcare business  Reuters

India's Lupin to spin off consumer healthcare business - Reuters

Click here to get full coverage on Trump Tariffs: Dr Reddys To Lupin — Pharma Stocks To Be In Focus After Threat Of 200% Levies - NDTV Profit

Trump Tariffs: Dr Reddys To Lupin — Pharma Stocks To Be In Focus After Threat Of 200% Levies  NDTV Profit

Trump Tariffs: Dr Reddys To Lupin — Pharma Stocks To Be In Focus After Threat Of 200% Levies - NDTV Profit

Click here to get full coverage on Lupin, Zentiva ink pact to commercialize arthritis drug Certolizumab Pegol - Medical Dialogues

Lupin, Zentiva ink pact to commercialize arthritis drug Certolizumab Pegol  Medical Dialogues

Lupin, Zentiva ink pact to commercialize arthritis drug Certolizumab Pegol - Medical Dialogues

Click here to get full coverage on 'Lupin' Season 4 begins production - upi.com

'Lupin' Season 4 begins production  upi.com

'Lupin' Season 4 begins production - upi.com

Click here to get full coverage on Lupin part 4 | Release date speculation and latest news - Radio Times

Lupin part 4 | Release date speculation and latest news  Radio Times

Lupin part 4 | Release date speculation and latest news - Radio Times

Click here to get full coverage on GMV shares LUPIN lunar navigation test results - GPS World

GMV shares LUPIN lunar navigation test results  GPS World

GMV shares LUPIN lunar navigation test results - GPS World

Click here to get full coverage on The white lupin CCR1 receptor-like kinase controls systemic Autoregulation of Cluster Root and Nodule Development - PNAS

The white lupin CCR1 receptor-like kinase controls systemic Autoregulation of Cluster Root and Nodule Development  PNAS

The white lupin CCR1 receptor-like kinase controls systemic Autoregulation of Cluster Root and Nodule Development - PNAS

Click here to get full coverage on Lupin the IIIrd: Zenigata to Futari no Lupin Anime Web Episode Shares Zenigata Character Trailer - Crunchyroll

Lupin the IIIrd: Zenigata to Futari no Lupin Anime Web Episode Shares Zenigata Character Trailer  Crunchyroll

Lupin the IIIrd: Zenigata to Futari no Lupin Anime Web Episode Shares Zenigata Character Trailer - Crunchyroll

Click here to get full coverage on Lupin the IIIrd the Movie: Fujimi no Ketsuzoku Reveals New Trailer, Cast and Visual - Crunchyroll

Lupin the IIIrd the Movie: Fujimi no Ketsuzoku Reveals New Trailer, Cast and Visual  Crunchyroll

Lupin the IIIrd the Movie: Fujimi no Ketsuzoku Reveals New Trailer, Cast and Visual - Crunchyroll

Click here to get full coverage on Lupin the IIIrd the Movie: Fujimi no Ketsuzoku Anime Film Debuts on June 27 - Crunchyroll

Lupin the IIIrd the Movie: Fujimi no Ketsuzoku Anime Film Debuts on June 27  Crunchyroll

Lupin the IIIrd the Movie: Fujimi no Ketsuzoku Anime Film Debuts on June 27 - Crunchyroll

Click here to get full coverage on Netflix's hit French thriller series Lupin might be coming back, but not as you know it - TechRadar

Netflix's hit French thriller series Lupin might be coming back, but not as you know it  TechRadar

Netflix's hit French thriller series Lupin might be coming back, but not as you know it - TechRadar

Click here to get full coverage on Lupin to focus on the development of inhalers with near-zero global warming potential propellants - PR Newswire

Lupin to focus on the development of inhalers with near-zero global warming potential propellants  PR Newswire

Lupin to focus on the development of inhalers with near-zero global warming potential propellants - PR Newswire

Click here to get full coverage on POM Anime Acquires Lupin the IIIrd The Movie and DAN DA DAN: Evil Eye - Deadline

POM Anime Acquires Lupin the IIIrd The Movie and DAN DA DAN: Evil Eye  Deadline

POM Anime Acquires Lupin the IIIrd The Movie and DAN DA DAN: Evil Eye - Deadline

Click here to get full coverage on 'Lupin' season 4: Everything we know so far - Tom's Guide

'Lupin' season 4: Everything we know so far  Tom's Guide

'Lupin' season 4: Everything we know so far - Tom's Guide

Click here to get full coverage on Omar Sy Suits Up as ‘Lupin’ Once Again for Season 4 - Collider

Omar Sy Suits Up as ‘Lupin’ Once Again for Season 4  Collider

Omar Sy Suits Up as ‘Lupin’ Once Again for Season 4 - Collider

Click here to get full coverage on ‘Lupin’ Returning for Season 4 - IMDb

‘Lupin’ Returning for Season 4  IMDb

‘Lupin’ Returning for Season 4 - IMDb

Click here to get full coverage on After 6 Years, a Criminally Underrated Anime Is Getting the Comeback Fans Gave Up On - Screen Rant

After 6 Years, a Criminally Underrated Anime Is Getting the Comeback Fans Gave Up On  Screen Rant

After 6 Years, a Criminally Underrated Anime Is Getting the Comeback Fans Gave Up On - Screen Rant

Click here to get full coverage on Netflix's 'flawless' crime thriller that's been watched by 100 million people - hellomagazine.com

Netflix's 'flawless' crime thriller that's been watched by 100 million people  hellomagazine.com

Netflix's 'flawless' crime thriller that's been watched by 100 million people - hellomagazine.com

Click here to get full coverage on I Avoided One of Anime's Best Classics Because It Was 'Old' Before Realizing My Mistake - Screen Rant

I Avoided One of Anime's Best Classics Because It Was 'Old' Before Realizing My Mistake  Screen Rant

I Avoided One of Anime's Best Classics Because It Was 'Old' Before Realizing My Mistake - Screen Rant

Click here to get full coverage on Lupin Part 4 Is Now Filming in Paris - Vital Thrills

Lupin Part 4 Is Now Filming in Paris  Vital Thrills

Lupin Part 4 Is Now Filming in Paris - Vital Thrills

Click here to get full coverage on Lupin Goes For Growth With Indian Consumer Health Spin-Off - insights.citeline.com

Lupin Goes For Growth With Indian Consumer Health Spin-Off  insights.citeline.com

Lupin Goes For Growth With Indian Consumer Health Spin-Off - insights.citeline.com

Click here to get full coverage on Netflix confirms ‘Lupin’ season 4 is happening — and production is already underway - Tom's Guide

Netflix confirms ‘Lupin’ season 4 is happening — and production is already underway  Tom's Guide

Netflix confirms ‘Lupin’ season 4 is happening — and production is already underway - Tom's Guide

Click here to get full coverage on India's Lupin recalls more than 600K bottles of blood pressure med over questionable API source - Fierce Pharma

India's Lupin recalls more than 600K bottles of blood pressure med over questionable API source  Fierce Pharma

India's Lupin recalls more than 600K bottles of blood pressure med over questionable API source - Fierce Pharma

Click here to get full coverage on 'Lupin' Renewed for Season 4 (Or Another Type of Return) at Netflix; Filming to Begin In 2025 - What's on Netflix

'Lupin' Renewed for Season 4 (Or Another Type of Return) at Netflix; Filming to Begin In 2025  What's on Netflix

'Lupin' Renewed for Season 4 (Or Another Type of Return) at Netflix; Filming to Begin In 2025 - What's on Netflix

Click here to get full coverage on Air-water interfacial and foaming properties of lupin protein-polysaccharide soluble complexes: Role of physicochemical properties, morphological characteristics, and flexibility - ScienceDirect.com

Air-water interfacial and foaming properties of lupin protein-polysaccharide soluble complexes: Role of physicochemical properties, morphological characteristics, and flexibility  ScienceDirect.com

Air-water interfacial and foaming properties of lupin protein-polysaccharide soluble complexes: Role of physicochemical properties, morphological characteristics, and flexibility - ScienceDirect.com

Click here to get full coverage on ‘Lupin’ Co-Writer François Uzan On Going Undercover In A School For Latest Netflix Project ‘Recalé’ — Series Mania - Deadline

‘Lupin’ Co-Writer François Uzan On Going Undercover In A School For Latest Netflix Project ‘Recalé’ — Series Mania  Deadline

‘Lupin’ Co-Writer François Uzan On Going Undercover In A School For Latest Netflix Project ‘Recalé’ — Series Mania - Deadline

Click here to get full coverage on Michael Lupin Obituary - Rochester, MI - Dignity Memorial

Michael Lupin Obituary - Rochester, MI  Dignity Memorial

Michael Lupin Obituary - Rochester, MI - Dignity Memorial

Click here to get full coverage on Buy, Sell Or Hold: Lupin, Prestige Estates, Praj Industries, Afcons Infra, Nalco — Ask Profit - NDTV Profit

Buy, Sell Or Hold: Lupin, Prestige Estates, Praj Industries, Afcons Infra, Nalco — Ask Profit  NDTV Profit

Buy, Sell Or Hold: Lupin, Prestige Estates, Praj Industries, Afcons Infra, Nalco — Ask Profit - NDTV Profit

Click here to get full coverage on Otsuka Pharm. Co., Ltd. v. Lupin Ltd. - Jynarque® (tolvaptan) - JD Supra

Otsuka Pharm. Co., Ltd. v. Lupin Ltd. - Jynarque® (tolvaptan)  JD Supra

Otsuka Pharm. Co., Ltd. v. Lupin Ltd. - Jynarque® (tolvaptan) - JD Supra

Click here to get full coverage on Anime's Global Takeover: One In Three Consumers Watch Weekly, 150 Million Netflix Subscribers Are Tuning In - Cartoon Brew

Anime's Global Takeover: One In Three Consumers Watch Weekly, 150 Million Netflix Subscribers Are Tuning In  Cartoon Brew

Anime's Global Takeover: One In Three Consumers Watch Weekly, 150 Million Netflix Subscribers Are Tuning In - Cartoon Brew

Click here to get full coverage on Development and validation of PCR marker array for molecular selection towards spring, vernalization-independent and winter, vernalization-responsive ecotypes of white lupin (Lupinus albus L.) | Scientific Reports - Nature

Development and validation of PCR marker array for molecular selection towards spring, vernalization-independent and winter, vernalization-responsive ecotypes of white lupin (Lupinus albus L.) | Scientific Reports  Nature

Development and validation of PCR marker array for molecular selection towards spring, vernalization-independent and winter, vernalization-responsive ecotypes of white lupin (Lupinus albus L.) | Scientific Reports - Nature

Click here to get full coverage on ‘Lupin’ Officially Renewed for Part 4, Will Consist of 8 Episodes With Production Underway - What's on Netflix

‘Lupin’ Officially Renewed for Part 4, Will Consist of 8 Episodes With Production Underway  What's on Netflix

‘Lupin’ Officially Renewed for Part 4, Will Consist of 8 Episodes With Production Underway - What's on Netflix

Click here to get full coverage on Lupin Announces the Acquisition of Renascience in the United Kingdom - Business Wire

Lupin Announces the Acquisition of Renascience in the United Kingdom  Business Wire

Lupin Limited (LUPIN)

Price Chart

Key Statistics

Technicals

About LUPIN

Latest News

Lupin receives FDA approval for generic Lotemax - Drug Store News

‘Lupin’ Returning for Season 4 - The Hollywood Reporter

Lupin Part 4 Is Now in Production in Paris - Netflix

Environment, Social and Governance (ESG) Risk Ratings

Controversy Level

Advanced Charts

Top Gainers

Top Losers